China’s Sinopharm: Efficacy rate of COVID-19 vaccine is 79.34%

CGTN published this video item, entitled “China’s Sinopharm: Efficacy rate of COVID-19 vaccine is 79.34%” – below is their description.

For more:

https://news.cgtn.com/news/2020-12-30/China-s-Sinopharm-Efficacy-rate-of-COVID-19-vaccine-is-79-34–WDREFG3ELm/index.html

China’s Sinopharm has just released its Phase III trial results. It says its vaccine has an antibody rate of 99.5 percent in participants, and the efficacy rate is 79.34 percent. Sinopharm says the results meet the vaccine standards set by the World Health Organization and China’s regulators. The company says it has applied to China’s drug regulator for approval of the vaccine. #Vaccine #Coronavirus #China

CGTN YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - CGTN

This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.

Recent from CGTN:

  • Huawei CFO back home in China: Triumph for Huawei? / Better days ahead for China-Canada ties?
  • Better Days Ahead for China-Canda Ties?
  • Huawei CFO back home in China: Triumph for Huawei?
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Norman Swan looks at the debate over COVID-19 vaccine booster shots | 7.30
  • IN FULL: Brad Hazzard provides NSW’s daily COVID-19 update | ABC News
  • Queensland detects four COVID-19 cases, Victoria to hit vaccine milestone today | 9 News Australia
  • NSW records 863 new local COVID-19 cases and seven deaths | Coronavirus | 9 News Australia
  • Home COVID-19 testing approved by TGA | Coronavirus | 9 News Australia
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • Zimbabwe receives fourth batch of COVID-19 vaccines from China
  • First batch of Chinese vaccines arrive in Kenya
  • In This Story: World Health Organization

    The World Health Organization is a specialized agency of the United Nations responsible for international public health. The WHO Constitution, which establishes the agency’s governing structure and principles, states its main objective as “the attainment by all peoples of the highest possible level of health.”

    3 Recent Items: World Health Organization

  • LIVE: Media briefing on WHO Academy
  • LIVE: WHO Academy Groundbreaking Ceremony with Dr Tedros and President Emmanuel Macron
  • Collaborating for an equitable recovery towards the health-related Sustainable Development Goals
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.